Showing results (451-460 of 491) with videos related to
Sort By:
Pageof 50
Nature Communications|January 4, 2020
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovarySarah H Kim, Arnaud Da Cruz Paula, Thais Basili, et al.The Journal of Pathology|April 12, 2022
Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervixSarah H Kim, Thais Basili, Higinio Dopeso, et al.Cancer|October 27, 2023
Pathogenic germline variants in patients with endometrial cancer of diverse ancestryYing L Liu, Sushmita Gordhandas, Kanika Arora, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Uterine neoplasms, version 1.2014Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 15, 2015
Cervical Cancer, Version 2.2015Wui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.The Lancet. Oncology|July 31, 2025
ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025Nicole Concin, Xavier Matias-Guiu, David Cibula, et al.Journal of Personalized Medicine|March 26, 2025
Trachelectomy and Cerclage Placement as Fertility-Sparing Surgery for Cervical Cancer-An Expert SurveyAnke Smits, Janneke T Wolswinkel, Mieke L G Ten Eikelder, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Cervical cancerWui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.JCO Precision Oncology|August 11, 2020
Understanding inherited risk in unselected newly diagnosed patients with endometrial cancerKaren A Cadoo, Diana L Mandelker, Semanti Mukherjee, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2025
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary TractRayan Rammal, Florestan J Koll, Ziyu Chen, et al.Pageof 50